Researchers have begun trials which will allow radiation doses in computed tomography (CT) scans to be estimated much more accurately.
A report in Science journal relating to gene patenting claimed: "Nearly a fifth of all human genes have been patented, a study has found, leading to fears that research into diseases such as breast cancer, diabetes and obesity could be stifled."
A discovery made at WEHI by the Cooperative Research Centre for Cellular Growth Factors (CRC-CGF) has led to the selection of an antibody-based drug for full preclinical development as a potential new treatment for asthma and other respiratory diseases.
Cannabis, a drug believed to increase the risk of psychosis in users, contains a compound that may be able to reverse psychotic behaviour, Monash researchers have found.
A malaria research team, including WEHI Structural Biologist, Professor Ray Norton, has received a US$1 million grant from the US National Institutes of Health to develop more effective malaria treatments.
A new combination of analytical chemistry and mathematical data analysis techniques allows the rapid identification of the species, strain and infectious phase of the potential biological terrorism agent Coxiella burnetii. The bacterium causes the human disease Q fever, which can cause serious illness and even death.
University of Queensland researchers have identified a protein that is crucially involved in how memories are stored and processed, paving the way for new strategies to treat conditions of certain mental disorders.
Dr Caroline Gargett from Monash Institute of Medical Research (MIMR) has discovered adult stem cells in the uterus that can be grown into bone, muscle, fat and cartilage and her research has been hailed as a major medical and scientific development by international reproduction experts.
Chemists at the University of California, Riverside have synthesised a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.
If living cell is replaced by a test-tube with DNA and a set of substances, it is possible to get proteins in a more simple and inexpensive way. That was done by Russian biochemists synthesising insulin without help of transgene Escherichia coli.
An analysis method permitting the simultaneous quantification of numerous parameters in the immune system was recently presented at the Campus Vienna Biocenter. The technology, which has been developed by Bender MedSystems, is based on the principle of a widespread analysis device and thus allows for rapid implementation in daily laboratory life. It thus succeeds in satisfying the growing demand at clinical and pharmaceutical organisations for increasingly efficient analysis methods at favourable costs.
Testable genetic differences might be used to predict the effectiveness of a medication commonly prescribed to treat attention deficit hyperactivity disorder, a new study suggests.
Researchers at The University of Texas MD Anderson Cancer Centre say they have discovered a potential oncongene in ovarian cancer, which is the leading cause of gynaecological cancer death in US women.
A portable biosensing device based on micro- and nanotechnologies is expected to help doctors rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
DiagnoSwiss and bioMerieux have signed an exclusive licence agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics.